Seattle

ADVANCED PRACTITIONER CONFERENCE 2018

Challenges in IBD and Practice Updates 2017 for the Advanced Practice provider

It is the gathering of the Advanced Practice Providers (APP) including Nurse Practitioners (NP), physician assistants (PA), IBD registered nurses (RN), pharmacists (PharmD) and medical assistants (MA). It is an opportunity not to be missed where you can meet and discuss key topics with colleagues within a highly favored group of a 150-200 participants.

Challenges in IBD and Practice Updates 2018 for the Advanced Practice provider Meeting offers you:

  • Relevant and engaging presentations by renowned speakers
  • A forum to collaborate with others and ask questions and share your experiences
  • A place to reflect upon and refine your own practices

Details

  • Cost: FREE
  • Credits: CME 6 Credits

Housing


  • Seattle Marriott Waterfront
  • 2100 Alaskan Way, Seattle, WA 98121
  • (206) 443-5000
  • We will soon have a link for discounted housing

Agenda


Topic
Breakfast
Start of meeting
Diagnostic Testing for IBD and risk stratification.
Starting, monitoring and potential side effects of Mesalamine and immune modulators
Beyond Conventional Therapy in IBD
How to obtain a biologic for a patient
Travel abroad for the patient with IBD
The expanding role of a pharmacist in treating the IBD patient
Diet and IBD – What really matters about diet and nutrition for IBD patients
Health maintenance for IBD patients
Ostomies

VENUE : BELL HARBOR CONFERENCE CENTER


Learning Objectives


  1. After completion of this activity, participants will be able to:1. Explain which diagnostic tests are best for the initial diagnosis of IBD.
  2. Explain how to interpret diagnostic testing when evaluating a patient for IBD.
  3. Appropriately choose the patients in whom to initiate, how to initiate, how to monitor and potential side effects of mesalamine, thiopurines and methotrexate in IBD.
  4. Describe the safety and efficacy of available biologics.
  5. Choose which biologic is appropriate for any given IBD patient.
  6. Explain the implications of the availability of biosimilars.
  7. Describe how to navigate the insurance approval for a biologic, including utilizing co-pay assistance or patient assistance programs.
  8. Explain how to take specific precautions for patients with IBD traveling abroad, including how to travel with a biologic medication.
  9. Explain a pharmacist’s role in treating and monitoring patients with IBD.
  10. Explain the standard of care for health maintenance for IBD patients with special considerations including cancer screening and immunizations for those on immune suppressive or biologic therapies.
  11. Describe the types of ostomies IBD patients might have and how to manage ostomies or comp

Media

CONFERENCE

Speakers



Scott

Lee


Anita

Afzali


Heidi

Drescher


Ghassan

Wahbeh


Betty

White

CME Supporters


Target Audience


This activity will be jointly provided by Global Education Group and IBD Horizons

This activity will most likely be supported by an educational grant from AbbVie, Janssen, Celgene, Prometheus Therapeutics & Diagnostics, Takeda Pharmaceuticals U.S.A, Inc. and UCB, Inc.